Figure 1From: Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional studyThe relationship between methotrexate use and the presence of the metabolic syndrome according to the definition used. * P < 0.05. EGIR = European Group Against Insulin Resistance; IDF = International Diabetes federation; NCEP = National Cholesterol Education Programme; WHO = World Health Organisation.Back to article page